Dr Daniel Ajzensztejn
/content/dam/genesiscare/centres-and-staff/uk-centres-and-staff/Daniel Ajzensztejn.jpg

Dr Daniel Ajzensztejn

Dr Daniel Ajzensztejn
Daniel
Ajzensztejn
Consultant Clinical Oncologist

Languages spoken

English

Expert in

Lung and skin cancers

Overview

Dr Ajzensztejn is a Consultant Clinical Oncologist specialising in the treatment of lung and skin cancers. Dr Ajzensztejn has a substantive NHS post providing chemotherapy, radiotherapy and stereotactic ablative body radiotherapy (SABR) to patients for the treatment of skin, lung and palliative cancers. He works out of Milton Keynes and Oxford. 

Dr Ajzensztejn is involved in a number of research trials including harnessing the immune system to reject cancers through genetic modifications of tumour cells. He is dedicated to providing the best possible care for his patients and is actively involved in research and learning new techniques and treatment modalities for his patients. 

Career positions

Current position(s)
  • University Hospitals Oxford 

Qualifications

  • 2016 FRCR. Royal College of Radiologists, Faculty of Clinical Oncology
  • 2015 DPhil. Tumour Immunology. Green Templeton College, University of Oxford
  • 2009 MSc Oncology. Institute of Cancer Research, University of London
  • 2005 MRCP. Royal College of Physicians of London
  • 1999 MBBS. University College London Medical School, University of London
  • 1997 BSc Pharmacology (Hons). University College London, University of London

Expertise and interests

  • Concurrent and sequential chemoradiotherapy
  • Radical radiotherapy
  • Adjuvant treatments
  • Lung malignancies
  • Respiratory medicine
  • Harnessing the immune system to reject cancers through genetic modifications of tumour cells